Kymera Therapeutics, Inc. (KYMR)
117.47
+0.19
(+0.16%)
USD |
NASDAQ |
Sep 04, 16:00
117.47
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Cash and Short Term Investments (Annual) : 848.28M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 848.28M |
| December 31, 2024 | 488.74M |
| December 31, 2023 | 374.88M |
| December 31, 2022 | 407.17M |
| Date | Value |
|---|---|
| December 31, 2021 | 442.42M |
| December 31, 2020 | 296.20M |
| December 31, 2019 | 91.96M |
| December 31, 2018 | 41.26M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 919.37M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |
| Sarepta Therapeutics, Inc. | 939.65M |
| Anixa Biosciences, Inc. | 15.17M |